M

Markella Konstantinidou

University of California, San Francisco

ORCID: 0000-0001-5972-4140

Publishes on 14-3-3 protein interactions, Ubiquitin and proteasome pathways, Synthesis and biological activity. 34 papers and 1.2k citations.

PubIndex Score80Top 20% · early-careerHow it's scored

🔥#1 Rising Star in 14-3-3 protein interactions

34Publications

1.2kTotal Citations

#1in 14-3-3 protein interactions

First publication: 2015First senior author: 2019

14-3-3 protein interactions Ubiquitin and proteasome pathways Synthesis and biological activity Microbial Natural Products and Biosynthesis Multicomponent Synthesis of Heterocycles

Top publicationsby citations

Covalent inhibitors: a rational approach to drug discovery

Fandi Sutanto, Alexander Dömlingꝉ, Markella Konstantinidou|RSC Medicinal Chemistry|2020

Cited by 375

PROTACs– a game-changing technology

Markella Konstantinidou, Alexander Dömlingꝉ, Jingyao Li et al.|Expert Opinion on Drug Discovery|2019

Cited by 159

Molecular glues for protein-protein interactions: Progressing toward a new dream

Markella Konstantinidou, Michelle R. Arkin|Cell chemical biology|2024

Cited by 139

Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?

Markella Konstantinidou, Alexander Dömlingꝉ, Tryfon Zarganes‐Tzitzikas et al.|Angewandte Chemie International Edition|2017

Cited by 133

Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)

Tryfon Zarganes‐Tzitzikas, Alexander Dömlingꝉ, Markella Konstantinidou et al.|Expert Opinion on Therapeutic Patents|2016

Cited by 104